Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Crohn's Disease (China multicenter observational)
ChiCTR-OPC-16008655Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of thalidomide in Crohn's disease (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Clinical remission rate and Mucosal healing rate. Started May 2016; status: recruiting.
02
Drugs
thalidomide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on ChiCTR-OPC-16008655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008655.